Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Pacific Biosciences of California (PACB) Stock Declines While Market Improves: Some Information for Investors
07:16pm, Wednesday, 22'nd Apr 2026
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.71, marking a -1.16% move from the previous day.
PacBio & Lucid Genomics Partner to Boost Data Analysis, Stock Up
11:56am, Wednesday, 22'nd Apr 2026
PACB stock gains on Lucid Genomics deal, boosting HiFi data analysis and simplifying workflows to speed insights and expand adoption.
PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing
09:05am, Tuesday, 21'st Apr 2026
Expands access to streamlined genomic data analysis across the PacBio partner ecosystem Expands access to streamlined genomic data analysis across the PacBio partner ecosystem
PacBio Stock Up on New FFPE Workflow Boosting Cancer Sequencing
11:10am, Friday, 17'th Apr 2026
PACB stock rises after unveiling a new FFPE workflow with Covaris, boosting HiFi sequencing accuracy and unlocking insights from archived tumor samples.
PacBio to Report First Quarter 2026 Financial Results on May 7, 2026
04:05pm, Thursday, 16'th Apr 2026
MENLO PARK, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2026 financial results on Thur
Why Pacific Biosciences of California (PACB) Outpaced the Stock Market Today
07:16pm, Wednesday, 15'th Apr 2026
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.6, marking a +1.91% move from the previous day.
PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
09:05am, Wednesday, 15'th Apr 2026
New extraction-to-library prep workflow enables highly accurate long-read sequencing from archived clinical samples, expanding opportunities in cancer research New extraction-to-library prep workflow
Three Best Genomics Stocks for Your Portfolio in 2026
11:20am, Monday, 13'th Apr 2026
Genomics gains momentum as breakthroughs, falling sequencing costs, and CRISPR advances drive precision medicine and fuel rapid market growth.
Pacific Biosciences of California (PACB) Laps the Stock Market: Here's Why
07:16pm, Tuesday, 07'th Apr 2026
Pacific Biosciences of California (PACB) closed the most recent trading day at $1.44, moving +1.41% from the previous trading session.
Financial Analysis: Pacific Biosciences of California (NASDAQ:PACB) versus DexCom (NASDAQ:DXCM)
01:40am, Tuesday, 07'th Apr 2026
Pacific Biosciences of California (NASDAQ: PACB - Get Free Report) and DexCom (NASDAQ: DXCM - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two
Here's Why You Should Add PacBio Stock to Your Portfolio Now
01:11pm, Wednesday, 01'st Apr 2026
PACB's strong Q4 results, expanding sequencing tech portfolio and rising system adoption highlight growth momentum despite ongoing purchasing cycle challenges.
Pacific Biosciences of California (PACB) Registers a Bigger Fall Than the Market: Important Facts to Note
07:15pm, Friday, 27'th Mar 2026
The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.26, representing a -6.67% change from its previous close.
PacBio Wins Basecamp Research Deal for Trillion Gene Atlas Initiative
10:06am, Thursday, 26'th Mar 2026
PACB wins Basecamp deal to power Trillion Gene Atlas using HiFi sequencing, advancing AI-driven drug discovery with high-accuracy genomic data.
Pacific Biosciences (PACB) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:00pm, Wednesday, 18'th Mar 2026
Pacific Biosciences (PACB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative
09:05am, Wednesday, 18'th Mar 2026
PacBio's Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics PacBio's Revio system and SPRQ-Nx chemistry to
